Blend Labs, Inc. filings document the company’s digital banking origination business, operating results, governance, capital actions, and material corporate events. Form 8-K reports cover quarterly and annual financial results, supplemental Regulation FD materials, product and service disclosures, officer-transition matters, and board-authorized repurchases of Class A common stock.
Blend’s proxy materials describe annual meeting matters, board elections, executive compensation, stockholder voting procedures, and related governance disclosures. Recent filings also document completed corporate actions, including the sale of substantially all assets and liabilities of Title365 Company, Blend’s former title insurance business.
Blend Labs (BLND) reported an equity grant to an officer on a Form 4. The Head of Finance and Administration received 2,200,000 restricted stock units (RSUs) on October 27, 2025, each representing one share of Class A common stock.
Per the award terms, 25% vests on August 20, 2026, with the remainder vesting in equal quarterly installments over the following three years, contingent on continued service. Following the grant, 2,200,000 derivative securities were reported as directly owned.
Blend Labs (BLND): insider equity change reported. A director and officer (Head of Blend) reported a transaction on 10/29/2025. The filing shows 371,000 shares of Class A Common Stock were acquired at a price of $0 under transaction code J, with total Class A beneficial ownership at 6,428,300 shares directly after the transaction.
The related note states that upon conversion of shares of Class B Common Stock, an equal number of Class A shares were pledged as collateral to secure certain personal indebtedness. Following the event, the reporting person also held 2,756,385 shares of Class B Common Stock, which are convertible into Class A on a one-for-one basis and have no expiration date.
Blend Labs (BLND) disclosed an insider transaction by its Head of Legal and People. On 10/20/2025, the reporting person sold 4,000 Class A shares at $3.50 per share under a Rule 10b5-1 trading plan adopted on March 14, 2025. Following the sale, the insider beneficially owned 380,631 shares, held directly.
Blend Labs (BLND) reported an insider transaction by its Head of Revenue. On 10/15/2025, the reporting person sold 25,000 shares of Class A common stock at a $3.3403 weighted average price, with individual trades ranging from $3.33 to $3.385. The sales were made under a Rule 10b5-1 trading plan adopted on March 14, 2025. Following the transaction, the insider beneficially owns 687,909 shares, held directly.
Blend Labs (BLND) received a Form 144 notice indicating an intended sale of 25,000 shares of common stock through Charles Schwab & Co., Inc. with an aggregate market value of $83,509, targeting an approximate sale date of October 15, 2025 on the NYSE. The form lists 255,696,747 shares outstanding.
The seller acquired these 25,000 shares on February 17, 2020 via “Exercise and Hold,” paid in cash. Recent activity disclosed three prior sales of 25,000 shares each on July 15, 2025 ($90,829), August 15, 2025 ($71,873), and September 15, 2025 ($109,069), by Brian Kneafsey.
Reporting person: Winnie Ling, Head of Legal and People and officer of Blend Labs, Inc. (BLND), reported a sale of common stock executed under a Rule 10b5-1 trading plan adopted on 03/14/2025.
The Form 4 shows a disposition of 4,000 shares of Class A common stock on 10/02/2025 for a weighted average sale price of $3.5845 per share (sales ranged from $3.545 to $3.65). After the reported sale, the reporting person beneficially owned 384,631 shares, held directly.
Blend Labs, Inc. outlined a transition for its previous Head of Finance and Administration, Amir Jafari. His employment ends on October 3, 2025, after which he will serve as a strategic advisor to the Head of Blend and the company through January 1, 2026.
During this advisor period, Jafari will receive payments equivalent to his regular base salary and company-paid COBRA benefits, and his outstanding equity awards will continue to vest under their existing terms. After the advisor period, and subject to his compliance with the transition terms and signing a supplemental release, he will receive an additional $200,000.
If, at any time during the advisor period, the closing price of Blend’s Class A common stock reaches at least $7.00 per share, then 325,000 performance-based restricted stock units from his March 13, 2025 grant will vest upon the effectiveness of the supplemental release.
Blend Labs, Inc. (BLND) filed a Form 144 reporting a proposed sale of 4,000 common shares through Charles Schwab & Co., Inc. with an approximate sale date of 10/02/2025 on the NYSE. The shares were acquired on 02/20/2025 as the lapse of restricted stock under the company’s equity compensation plan and were paid by equity compensation.
The filing also lists multiple recent open-market sales by (and an address for) Winnie Ling across July–September 2025, each showing trade dates, share amounts, and gross proceeds. The Form 144 includes the seller’s representation that they are not aware of undisclosed material adverse information about the issuer.
Winnie Ling, Head of Legal and People at Blend Labs, Inc. (BLND), reported a sale of 6,500 shares of Class A common stock on 09/18/2025. The shares were sold under a pre-established Rule 10b5-1 trading plan adopted on March 14, 2025, at a weighted average price of $4.2951 per share (sales ranged from $4.265 to $4.30). After the transaction, the reporting person beneficially owned 388,631 shares, held directly. The Form 4 was signed on 09/19/2025 and includes an offer to provide detailed per-price sale quantities to the Commission staff on request.
Winnie Ling, Head of Legal and People at Blend Labs, Inc. (BLND), reported a sale of 6,500 shares of Class A common stock on 09/18/2025. The shares were sold under a pre-established Rule 10b5-1 trading plan adopted on March 14, 2025, at a weighted average price of $4.2951 per share (sales ranged from $4.265 to $4.30). After the transaction, the reporting person beneficially owned 388,631 shares, held directly. The Form 4 was signed on 09/19/2025 and includes an offer to provide detailed per-price sale quantities to the Commission staff on request.
Form 144 notice for Blend Labs, Inc. (BLND)
This filing discloses a proposed sale of 6,500 common shares to be executed on 09/18/2025 through Charles Schwab & Co., with an aggregate market value listed as $27,918.00. The shares were acquired by the seller on 05/20/2024 via a restricted stock lapse as equity compensation from Blend Labs, Inc. The filing also reports prior sales by the same person, Winnie Ling, totaling 45,500 shares sold across seven transactions between 07/03/2025 and 09/05/2025, with aggregate gross proceeds of $169,091.00. The filer certifies no undisclosed material adverse information and follows Rule 144 disclosure requirements.
Form 144 notice for Blend Labs, Inc. (BLND)
This filing discloses a proposed sale of 6,500 common shares to be executed on 09/18/2025 through Charles Schwab & Co., with an aggregate market value listed as $27,918.00. The shares were acquired by the seller on 05/20/2024 via a restricted stock lapse as equity compensation from Blend Labs, Inc. The filing also reports prior sales by the same person, Winnie Ling, totaling 45,500 shares sold across seven transactions between 07/03/2025 and 09/05/2025, with aggregate gross proceeds of $169,091.00. The filer certifies no undisclosed material adverse information and follows Rule 144 disclosure requirements.